Affordable Access

deepdyve-link
Publisher Website

Plasmapheresis in cast nephropathy: yes or no?

Authors
  • Madore, François1
  • 1 Department of Nephrology, Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada. , (Canada)
Type
Published Article
Journal
Current opinion in nephrology and hypertension
Publication Date
Mar 01, 2015
Volume
24
Issue
2
Pages
177–182
Identifiers
DOI: 10.1097/MNH.0000000000000101
PMID: 25590785
Source
Medline
License
Unknown

Abstract

Plasmapheresis is theoretically attractive as a means of rapidly lowering serum FLC burden in the hope of reducing nephrotoxicity in patients with multiple myeloma. However, the role of plasmapheresis in improving renal prognosis and patient survival remains to be demonstrated.

Report this publication

Statistics

Seen <100 times